首页 | 本学科首页   官方微博 | 高级检索  
检索        


Responses of human hepatoma HepG2 cells to silver nanoparticles and polycyclic aromatic hydrocarbons
Authors:Francisco Filipak Neto  Ludiana Cardoso da Silva  Samuel Liebel  Carmen Lúcia Voigt  Ciro Alberto de Oliveira Ribeiro
Institution:1. Departamento de Biologia Celular, Universidade Federal do Paraná, Curitiba, PR Brazil;2. filipak@ufpr.br;4. Programa Associado de Pós-Gradua??o em Química, Universidade Estadual de Ponta Grossa, Ponta Grossa, PR Brazil
Abstract:The nanotechnology has revolutionized the global market with silver nanoparticles (AgNP) occupying a prominent position due to their remarkable anti-bacterial properties. However, there is no data about the adverse and toxic effects of associations of AgNP and ubiquitous compounds, such as polycyclic aromatic hydrocarbons (PAH). In the current study, we investigated the responses of HepG2 cells to realistic concentrations of AgNP (0.09, 0.9, and 9?ng ml?1) and mixture of PAH (30 and 300?ng ml?1), separately and in association. Cell viability and cytotoxicity (neutral red retention and MTT production assays) and proliferation (crystal violet CV] assay), xenobiotic efflux transporter activity (rhodamine B accumulation assay), ROS levels (dichlorodihydrofluorescein diacetate assay), and lipid peroxidation (pyrenylphosphine-1-diphenyl assay) were analyzed. There was no decreases of cell viability after exposure to AgNP, PAH and most of AgNP?+?PAH associations, but increases of cell viability/number (CV assay) occurred. Efflux transporter activity was not affected, with exception of one AgNP?+?PAH associations, ROS levels increased, but lipid peroxidation decreased. Some toxicological interactions occurred, particularly for the highest concentrations of AgNP and PAH, but there is no evidence that these interactions increased the toxicity of AgNP and PAH.
Keywords:Silver nanoparticles  polycyclic aromatic hydrocarbons  HepG2  proliferation  toxicological interaction
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号